1. 12 week PET-CT has low positive predictive value for nodal residual disease in human papillomavirus-positive oropharyngeal cancers. (October 2019) Authors: Rulach, Robert; Zhou, Suyun; Hendry, Fraser; Stobo, David; James, Allan; Dempsey, Mary-Frances; Grose, Derek; Lamb, Carolynn; Schipani, Stefano; Rizwanullah, Mohammed; Wilson, Christina; Paterson, Claire Journal: Oral oncology Issue: Volume 97(2019) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of VMAT (volumetric modulated arc therapy) delivery of high-dose palliative radiotherapy (RT) to lung via Eclipse Planning System (EPS), to conventional palliative radiotherapy delivery via ADW planning system. (April 2023) Authors: Walker, Sara; Rulach, Robert; Featherstone, Carrie; Kirby, Gavin; Laverick, Nicola; Peters, Adam; Moore, Karen Journal: Lung cancer Issue: Volume 178(2023)Supplement 1 Page Start: S60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Letter to editor regarding Urban et al., FDG-PET/CT scan assessment of response 12 weeks post radical radiotherapy in oropharynx head and neck cancer: The impact of p16 status. (September 2020) Authors: Rulach, Robert; Zhou, Suyun; Paterson, Claire Journal: Radiotherapy and oncology Issue: Volume 150(2020) Page Start: 150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection. (May 2022) Authors: Zhou, Suyun; Chan, Christopher; Rulach, Robert; Dyab, Hesham; Hendry, Fraser; Maxfield, Carole; Dempsey, Mary-Frances; James, Allan; Grose, Derek; Lamb, Carolynn; Schipani, Stefano; Wilson, Christina; Cheng Lau, Yee; Paterson, Claire Journal: Oral oncology Issue: Volume 128(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pembrolizumab for advanced non-small cell lung cancer (NSCLC): Impact of autoimmune comorbidity and outcomes following treatment completion. (June 2023) Authors: Ansel, Sonam; Rulach, Robert; Trotter, Nicola; Steele, Nicola Journal: Journal of oncology pharmacy practice Issue: Volume 29:Number 4(2023) Page Start: 785 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Preliminary results of a qualitative interview study investigating patients' attitudes to radical re-irradiation of non-small cell lung cancer. (April 2023) Authors: Rulach, Robert; MacLean, Louise; Dornan, Lucy; Moore, Karen; Harrow, Stephen; Robb, Katie Journal: Lung cancer Issue: Volume 178(2023)Supplement 1 Page Start: S87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗